Researchers launch Phase 1 clinical trial of potential MRSA treatment
Scientists have begun the first human clinical trial of EDP-788, an investigational oral antibiotic intended to treat methicillin-resistant Staphylococcus aureus (MRSA) infections. The Phase 1 trial, which will enroll as ...
Jan 27, 2014
0
0